
### [MONDO:0021034](http://purl.obolibrary.org/obo/MONDO_0021034)
**Label:** genetic alopecia

**Subclasses:** [MONDO:0018657](http://purl.obolibrary.org/obo/MONDO_0018657) (pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome), [MONDO:0019414](http://purl.obolibrary.org/obo/MONDO_0019414) (BRESEK syndrome), [MONDO:0013268](http://purl.obolibrary.org/obo/MONDO_0013268) (frontonasal dysplasia with alopecia and genital anomaly), [MONDO:0013492](http://purl.obolibrary.org/obo/MONDO_0013492) (APMR3), [MONDO:0012487](http://purl.obolibrary.org/obo/MONDO_0012487) (alopecia-mental retardation syndrome 2), [MONDO:0011452](http://purl.obolibrary.org/obo/MONDO_0011452) (hypotrichosis 7), [MONDO:0012794](http://purl.obolibrary.org/obo/MONDO_0012794) (ANE syndrome), [MONDO:0012551](http://purl.obolibrary.org/obo/MONDO_0012551) (AA2), [MONDO:0021035](http://purl.obolibrary.org/obo/MONDO_0021035) (alopecia-mental retardation syndrome 1), [MONDO:0018021](http://purl.obolibrary.org/obo/MONDO_0018021) (hypotrichosis-deafness syndrome), [MONDO:0008756](http://purl.obolibrary.org/obo/MONDO_0008756) (alopecia-intellectual disability syndrome), [MONDO:0008757](http://purl.obolibrary.org/obo/MONDO_0008757) (alopecia universalis), [MONDO:0000687](http://purl.obolibrary.org/obo/MONDO_0000687) (diffuse alopecia areata), [MONDO:0019080](http://purl.obolibrary.org/obo/MONDO_0019080) (alopecia totalis), [MONDO:0014608](http://purl.obolibrary.org/obo/MONDO_0014608) (mandibulofacial dysostosis with alopecia), [MONDO:0005340](http://purl.obolibrary.org/obo/MONDO_0005340) (alopecia areata), [MONDO:0010206](http://purl.obolibrary.org/obo/MONDO_0010206) (hypotrichosis 8), [MONDO:0007085](http://purl.obolibrary.org/obo/MONDO_0007085) (alopecia-epilepsy-pyorrhea-intellectual disability syndrome), [MONDO:0010624](http://purl.obolibrary.org/obo/MONDO_0010624) (ichthyosis follicularis-alopecia-photophobia syndrome), [MONDO:0010922](http://purl.obolibrary.org/obo/MONDO_0010922) (Satoyoshi syndrome), [MONDO:0010229](http://purl.obolibrary.org/obo/MONDO_0010229) (alopecia, congenital), [MONDO:0011218](http://purl.obolibrary.org/obo/MONDO_0011218) (autosomal recessive congenital ichthyosis 11), [MONDO:0011899](http://purl.obolibrary.org/obo/MONDO_0011899) (Noonan syndrome-like disorder with loose anagen hair), [MONDO:0007082](http://purl.obolibrary.org/obo/MONDO_0007082) (alopecia areata 1), 

**Mapped go classes:** [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0009791](http://purl.obolibrary.org/obo/GO_0009791) (post-embryonic development), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0000976](http://purl.obolibrary.org/obo/GO_0000976) (transcription regulatory region sequence-specific DNA binding), [GO:0046579](http://purl.obolibrary.org/obo/GO_0046579) (positive regulation of Ras protein signal transduction), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0004222](http://purl.obolibrary.org/obo/GO_0004222) (metalloendopeptidase activity), [GO:0042733](http://purl.obolibrary.org/obo/GO_0042733) (embryonic digit morphogenesis), [GO:0004620](http://purl.obolibrary.org/obo/GO_0004620) (phospholipase activity), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0051482](http://purl.obolibrary.org/obo/GO_0051482) (positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0035115](http://purl.obolibrary.org/obo/GO_0035115) (embryonic forelimb morphogenesis), [GO:0035116](http://purl.obolibrary.org/obo/GO_0035116) (embryonic hindlimb morphogenesis), [GO:0019888](http://purl.obolibrary.org/obo/GO_0019888) (protein phosphatase regulator activity), [GO:0070915](http://purl.obolibrary.org/obo/GO_0070915) (lysophosphatidic acid receptor activity), [GO:0019903](http://purl.obolibrary.org/obo/GO_0019903) (protein phosphatase binding), [GO:0042826](http://purl.obolibrary.org/obo/GO_0042826) (histone deacetylase binding), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0007389](http://purl.obolibrary.org/obo/GO_0007389) (pattern specification process), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0043433](http://purl.obolibrary.org/obo/GO_0043433) (negative regulation of DNA binding transcription factor activity), [GO:0007265](http://purl.obolibrary.org/obo/GO_0007265) (Ras protein signal transduction), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0035108](http://purl.obolibrary.org/obo/GO_0035108) (limb morphogenesis), [GO:0033169](http://purl.obolibrary.org/obo/GO_0033169) (histone H3-K9 demethylation), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0071837](http://purl.obolibrary.org/obo/GO_0071837) (HMG box domain binding), [GO:0035025](http://purl.obolibrary.org/obo/GO_0035025) (positive regulation of Rho protein signal transduction), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0000118](http://purl.obolibrary.org/obo/GO_0000118) (histone deacetylase complex), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0042310](http://purl.obolibrary.org/obo/GO_0042310) (vasoconstriction), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0004962](http://purl.obolibrary.org/obo/GO_0004962) (endothelin receptor activity), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0000164](http://purl.obolibrary.org/obo/GO_0000164) (protein phosphatase type 1 complex), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0036500](http://purl.obolibrary.org/obo/GO_0036500) (ATF6-mediated unfolded protein response), [GO:0010155](http://purl.obolibrary.org/obo/GO_0010155) (regulation of proton transport), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0031293](http://purl.obolibrary.org/obo/GO_0031293) (membrane protein intracellular domain proteolysis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0008217](http://purl.obolibrary.org/obo/GO_0008217) (regulation of blood pressure), [GO:0048704](http://purl.obolibrary.org/obo/GO_0048704) (embryonic skeletal system morphogenesis), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0046966](http://purl.obolibrary.org/obo/GO_0046966) (thyroid hormone receptor binding), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:1990440](http://purl.obolibrary.org/obo/GO_1990440) (positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress), [GO:0007517](http://purl.obolibrary.org/obo/GO_0007517) (muscle organ development), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0003319](http://purl.obolibrary.org/obo/GO_0003319) (cardioblast migration to the midline involved in heart rudiment formation), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:0032454](http://purl.obolibrary.org/obo/GO_0032454) (histone demethylase activity (H3-K9 specific)), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0042809](http://purl.obolibrary.org/obo/GO_0042809) (vitamin D receptor binding), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0052689](http://purl.obolibrary.org/obo/GO_0052689) (carboxylic ester hydrolase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.13%
- [GO:1990440](http://purl.obolibrary.org/obo/GO_1990440) (positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress) 52.08%
- [GO:0071837](http://purl.obolibrary.org/obo/GO_0071837) (HMG box domain binding) 52.08%
- [GO:0070915](http://purl.obolibrary.org/obo/GO_0070915) (lysophosphatidic acid receptor activity) 52.08%
- [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity) 52.08%
- [GO:0046966](http://purl.obolibrary.org/obo/GO_0046966) (thyroid hormone receptor binding) 52.08%
- [GO:0042826](http://purl.obolibrary.org/obo/GO_0042826) (histone deacetylase binding) 52.08%
- [GO:0042809](http://purl.obolibrary.org/obo/GO_0042809) (vitamin D receptor binding) 52.08%
- [GO:0036500](http://purl.obolibrary.org/obo/GO_0036500) (ATF6-mediated unfolded protein response) 52.08%
- [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding) 52.08%
- [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm) 52.08%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 52.08%
- [GO:0004962](http://purl.obolibrary.org/obo/GO_0004962) (endothelin receptor activity) 52.08%
- [GO:0003319](http://purl.obolibrary.org/obo/GO_0003319) (cardioblast migration to the midline involved in heart rudiment formation) 52.08%
- [GO:0000164](http://purl.obolibrary.org/obo/GO_0000164) (protein phosphatase type 1 complex) 52.08%


